# Nightingale Health Oyj > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/nightingalehealth). ## Overview Nightingale Health is a Finnish health technology company focused on creating sustainable healthcare solutions and reducing healthcare inequality. The company has developed an advanced health test that identifies risks for major chronic diseases from a single blood sample. This test can be scaled to entire populations at low cost, potentially replacing many existing routine healthcare tests. Nightingale Health aims to collaborate with healthcare providers to help millions prevent lifestyle diseases and reduce healthcare costs. ## Products & services • Advanced health test for chronic disease risk • Health Check product family • Large language model-based interactive tool • National-scale health test implementations • Pilot projects for healthcare technology integration - **Health Testing** (60%) — Includes advanced blood tests for chronic disease risk identification - **Health Check Products** (20%) — Comprises new risk identification products like metabolic fatty liver disease and stroke - **Technology Integration** (20%) — Involves pilot projects and national-scale implementations of health tests - Advanced health test for chronic disease risk - Health Check product family - Large language model-based interactive tool - National-scale health test implementations - Pilot projects for healthcare technology integration ## Customers Nightingale Health serves healthcare and research clients across more than 34 countries. Their customer base includes national biobanks, healthcare providers, and research institutions. The company's technology is utilized in major health projects, such as the UK Biobank. Customers choose Nightingale Health for its ability to provide comprehensive risk assessments for chronic diseases, enabling targeted healthcare interventions and preventive measures. - **Healthcare Providers** (primary) — Buy health tests to replace routine tests and target preventive care - **Research Institutions** (secondary) — Use technology for large-scale population studies - **National Biobanks** (emerging) — Integrate health data for comprehensive risk assessments - Healthcare providers seeking cost-effective disease risk assessments - Research institutions requiring advanced analytical tools for population studies - National biobanks integrating comprehensive health data - Healthcare systems aiming to reduce costs through preventive measures ## Geography Nightingale Health is headquartered in Finland, with subsidiaries in the UK, Japan, Sweden, Germany, Singapore, Estonia, and the USA. The company has a significant global presence, serving clients in over 34 countries. Its technology is used in leading health projects worldwide, including the UK Biobank. This geographic diversity helps mitigate risks associated with local market fluctuations and regulatory changes. - Headquartered in Finland with subsidiaries in multiple countries - Serves clients in over 34 countries globally - Technology used in major global health projects like UK Biobank - Geographic diversity reduces local market risk exposure ## Strategy Nightingale Health's strategic priorities include expanding international agreements and converting pilot projects into commercial contracts. The company aims to grow revenue despite the typically long conversion time of new contracts. It also focuses on improving operational efficiency while maintaining a strong cash position to ensure business continuity. In the medium to long term, the company seeks to expand its laboratory capacity to meet increasing demand and achieve positive EBITDA. - **Expand international agreements** (medium-term) — To increase global market presence and revenue - **Improve operational efficiency** (short-term) — To maintain financial stability and support growth - **Expand laboratory capacity** (long-term) — To meet increasing demand for health tests - Expand international agreements and convert pilots to commercial contracts - Grow revenue despite long conversion times for new contracts - Improve operational efficiency while maintaining strong cash position - Expand laboratory capacity to meet demand and achieve positive EBITDA ## Risks Key risks for Nightingale Health include dependence on key personnel, potential delays in technology adoption, and regulatory compliance challenges. The company is also exposed to risks related to intellectual property protection and competition in the health technology sector. Additionally, financial risks stem from the need to scale operations and maintain profitability amidst evolving market conditions. - **Dependence on key personnel** [high] — Loss of key staff could impact operations and competitive position - **Regulatory compliance** [medium] — Complex regulations across different markets could hinder operations - **Intellectual property protection** [high] — Unauthorized use of proprietary technology could harm competitive edge - Dependence on key personnel and potential talent retention issues - Delays in technology adoption and integration in healthcare systems - Regulatory compliance challenges in multiple jurisdictions - Intellectual property protection and competition risks - Financial risks from scaling operations and maintaining profitability ## Accounting Nightingale Health's revenue recognition involves significant judgment, particularly in the timing of recognizing revenue from advance payments. The company uses a method based on the proportion of analyzed samples to total samples to recognize revenue over time. This approach reflects the transfer of control of promised services to customers. The company's accounting practices also involve managing contract liabilities and assets, which can significantly impact financial statements. - **Revenue recognition timing** — high - **Contract liabilities and assets** — medium - Revenue recognized over time based on analyzed sample proportion - Advance payments recorded as contract liabilities until analysis completion - Judgment required in timing of revenue recognition from advance payments - Contract liabilities and assets management impacts financial statements --- *Last updated: 2026-08-11T04:04:54.838354+00:00*